~~<i id='ACC4999894'><strike id='ACC4999894'><tt id='ACC4999894'><pre id='ACC4999894'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：entertainment 2025-09-30 07:26:44 Page View：272

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
Next article： Drug repurposing or repositioning? The language matters

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

FDA warns medical device makers about rise in fabricated data

ManuelBalceCeneta/APAnincreasingnumberofmedicaldevicecompaniesaresubmittingfabricatedandunreliableda

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

TheProLondietincludesallthecaloriesyou'lleatforfivedays,packagedinasmallwhitebox.UshaLeeMcFarling/ST